How pharmacies feel about Optum Rx’s new reimbursement strategy
The PBM says it will now reimburse pharmacies based on the cost to acquire drugs.
Stay updated on PBMs trends and industry impact. Healthcare Brew provides the latest news and professional analysis on PBMs's role in PBMs & Reimbursement and Retail Pharmacies.
The PBM says it will now reimburse pharmacies based on the cost to acquire drugs.
The report is the second from the agency’s investigation of PBMs and comes amid a flurry of lawsuits.
While CVS and Walgreens are both facing challenges with retail pharmacies, CVS has an advantage due to its PBM and size.
The federal agency sued the PBMs in September alleging they unfairly boosted profits by raising insulin costs.
The three largest PBMs made about $1.6 billion in excess revenue on two cancer drugs in less than three years, according to the report.
These companies play a crucial role in setting drug prices.
Rite Aid spent billions on Elixir, but it may not have lived up to expectations.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.